申请人:University of Tennessee Research Foundation
公开号:US10301285B2
公开(公告)日:2019-05-28
The present invention relates to a compound of formula XXII and a compound of formula 17ya, which are defined as anywhere in the specification, to a composition comprising the same, and to a method of using thereof in the treatment of various forms of cancer.
本发明涉及一种式 XXII 化合物和一种式 17ya 化合物(在说明书的任何地方都有定义),涉及一种包含这些化合物的组合物,还涉及一种将其用于治疗各种癌症的方法。